The Discovery of Obeticholic Acid (Ocaliva™): First‐in‐ClassFXRAgonist
Authors:
- 16 April 2018
- book chapter
- Published by Wiley
- p. 197-244
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 ModulatorsACS Medicinal Chemistry Letters, 2012
- Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbeneBioorganic & Medicinal Chemistry Letters, 2011
- Tissue-specific function of farnesoid X receptor in liver and intestinePharmacological Research, 2011
- Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and DiabetesThe Journal of Sexual Medicine, 2011
- Bile acid toxicity structure–activity relationships: Correlations between cell viability and lipophilicity in a panel of new and known bile acids using an oesophageal cell line (HET-1A)Bioorganic & Medicinal Chemistry, 2010
- High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitisHepatology, 2010
- Update on primary biliary cirrhosisDigestive and Liver Disease, 2010
- Exposure to the synthetic FXR agonist GW4064 causes alterations in gene expression and sublethal hepatotoxicity in eleutheroembryo medaka (Oryzias latipes)Toxicology and Applied Pharmacology, 2010
- Derived chromatographic indices as effective tools to study the self-aggregation process of bile acidsJournal of Pharmaceutical and Biomedical Analysis, 2009
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseHepatology, 2008